doi: 10.1038/s41419-023-06175-3 34 LiAYiBHanHYangSHuZZhengLet al
Some of these other things that later down the line you can finally use the medications
In obese patients, taking semaglutide means lowering blood sugar levels, possibly even to hypoglycemic levels (which is a medical problem and needs to be addressed, so don't ignore it if it's significant.) In diabetics, whose blood sugar is already dysregulated and often too high, it simply lowers blood sugar to a more stable range
For researchers in Canada who want to review the current option available through Great Northern Peptides, see the retatrutide page here
Patient Eligibility and Clinical Considerations Primary care doctors typically assess GLP-1 candidacy using BMI, comorbidity status (diabetes, hypertension, cardiovascular disease), contraindications, and medication interactions